Cellectis (CLLS) Pension (2022 - 2023)

Cellectis (CLLS) posted quarterly Pension of $2.6 million for Q2 2023, up 10.5% quarter-over-quarter from $2.4 million in Q4 2022.

Cellectis (CLLS) Pension (2022 - 2023) Analysis & Trends

Cellectis' Pension history runs 2 years deep, the most recent figure standing at $2.6 million for Q2 2023.

In Q2 2023, Pension changed N/A year-over-year to $2.6 million; the TTM figure through Jun 2023 stood at $2.6 million (changed N/A YoY), while the FY2022 annual figure was $2.4 million, changed N/A from the prior year.
Pension for Q2 2023 stood at $2.6 million, up from $2.4 million in the prior quarter.
The five-year high for Pension was $2.6 million in Q2 2023, with the low at $2.4 million in Q4 2022.

Peer Comparison

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Vertex Pharmaceuticals	128.13 Bn	120.28 Bn	2.84 Bn
2	Regeneron Pharmaceuticals	112.33 Bn	104.33 Bn	3.93 Bn
3	Argenx Se	53.24 Bn	48.05 Bn	1.41 Bn
4	Revolution Medicines	43.64 Bn	43.64 Bn	-
5	BeOne Medicines	39.27 Bn	34.17 Bn	1.53 Bn
6	MindWalk Holdings	35.32 Bn	35.31 Bn	1.82 Bn
7	Royalty Pharma	33.72 Bn	35.84 Bn	-
8	Alnylam Pharmaceuticals	30.58 Bn	27.27 Bn	992.69 Mn
9	Insmed	27.01 Bn	25.85 Bn	358.27 Mn
10	Cellectis	306.61 Mn	120.95 Mn	-

Historic Data

Download Data

Date	Value
Jun 30, 2023	2.64 Mn
Dec 31, 2022	2.39 Mn